Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Ordinary Shares / American Depositary Shares
-
Shares outstanding
-
412,914,375
-
Total 13F shares
-
2,813,782
-
Share change
-
+283,206
-
Total reported value
-
$1,434,861
-
Price per share
-
$0.51
-
Number of holders
-
16
-
Value change
-
+$143,796
-
Number of buys
-
8
-
Number of sells
-
3
Institutional Holders of Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) as of Q4 2023
As of 31 Dec 2023,
Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,813,782 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Ikarian Capital, LLC, MORGAN STANLEY, TWO SIGMA INVESTMENTS, LP, TWO SIGMA ADVISERS, LP, CITADEL ADVISORS LLC, KESTRA PRIVATE WEALTH SERVICES, LLC, XTX Topco Ltd, BOOTHBAY FUND MANAGEMENT, LLC, and Virtu Financial LLC.
This page lists
16
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.